This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through November 3, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
style-scores: Archive
Aveanna Healthcare Holdings Inc. (AVAH) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Aveanna (AVAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
AVAHNegative Net Change EHCPositive Net Change
earnings-surprise price-change style-scores valuation
Backblaze, Inc. (BLZE) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Backblaze (BLZE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
BLZENegative Net Change KARONegative Net Change
earnings-surprise price-change style-scores valuation
Rigel Pharmaceuticals, Inc. (RIGL) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Rigel (RIGL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
RIGLNegative Net Change AMRXNegative Net Change
earnings-surprise price-change style-scores valuation
ANI Pharmaceuticals, Inc. (ANIP) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
ANI (ANIP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
ANIPNegative Net Change
earnings-surprise price-change style-scores valuation
CBRE Group, Inc. (CBRE) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
CBRE (CBRE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
CBRENegative Net Change FSVPositive Net Change
earnings-surprise price-change style-scores valuation
Encompass Health Corporation (EHC) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
EHCPositive Net Change AVAHNegative Net Change
earnings-surprise price-change style-scores valuation
Phibro Animal Health Corporation (PAHC) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Phibro (PAHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
PAHCNegative Net Change BWAYNegative Net Change
earnings-surprise price-change style-scores valuation
Grand Canyon Education, Inc. (LOPE) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Grand Canyon Education (LOPE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
LOPENegative Net Change LRNPositive Net Change
earnings-surprise price-change style-scores valuation
Brainsway Ltd. Sponsored ADR (BWAY) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
BWAYNegative Net Change VREXNegative Net Change
earnings-surprise price-change style-scores valuation
LendingTree, Inc. (TREE) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Tree.com (TREE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
TREENegative Net Change
earnings-surprise price-change style-scores valuation
Dillard's, Inc. (DDS) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Dillard's (DDS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
DDSNegative Net Change
earnings-surprise price-change style-scores valuation
Douglas Dynamics, Inc. (PLOW) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Douglas Dynamics (PLOW) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
PLOWNegative Net Change SMPNegative Net Change
earnings-surprise price-change style-scores valuation
Hasbro, Inc. (HAS) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Hasbro (HAS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
HASNegative Net Change
earnings-surprise price-change style-scores valuation
Intercorp Financial Services Inc. (IFS) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Intercorp Financial Services (IFS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
IFSPositive Net Change PJTNegative Net Change
earnings-surprise price-change style-scores valuation
The Ensign Group, Inc. (ENSG) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Ensign Group (ENSG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
ENSGPositive Net Change
earnings-surprise price-change style-scores valuation
Primoris Services Corporation (PRIM) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Primoris Services (PRIM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
PRIMNegative Net Change GLDDNegative Net Change
earnings-surprise price-change style-scores valuation
Xometry, Inc. (XMTR) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Xometry (XMTR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
XMTRNegative Net Change GRCPositive Net Change
earnings-surprise price-change style-scores valuation
Adaptive Biotechnologies Corporation (ADPT) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Adaptive Biotechnologies (ADPT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
ADPTPositive Net Change PBYIPositive Net Change
earnings-surprise price-change style-scores valuation
Dorman Products, Inc. (DORM) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Dorman Products (DORM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
DORMNegative Net Change PLOWNegative Net Change
earnings-surprise price-change style-scores valuation
Visteon Corporation (VC) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Visteon (VC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
VCNegative Net Change KARNegative Net Change
earnings-surprise price-change style-scores valuation
Valmont Industries, Inc. (VMI) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Valmont (VMI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
VMINegative Net Change
earnings-surprise price-change style-scores valuation
Vontier Corporation (VNT) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Vontier (VNT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
VNTNegative Net Change SPXCNegative Net Change
earnings-surprise price-change style-scores valuation
Puma Biotechnology, Inc. (PBYI) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Puma Biotech (PBYI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
PBYIPositive Net Change
earnings-surprise price-change style-scores valuation
Xeris Biopharma Holdings, Inc. (XERS) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Xeris Biopharma (XERS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
XERSPositive Net Change RIGLNegative Net Change
earnings-surprise price-change style-scores valuation
REV Group, Inc. (REVG) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
REV Group (REVG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
REVGNegative Net Change
earnings-surprise price-change style-scores valuation